Core Insights - Guoke Ion Medical Technology Co., Ltd. has successfully raised 800 million yuan in its first round of equity financing, led by the Social Security Fund's Zhongguancun Independent Innovation Special Fund and Junlian Capital, with additional investment from existing shareholder Xiamen Guomao [1][2] Group 1: Company Overview - Guoke Ion aims to create a comprehensive heavy ion therapy industry that integrates high-end equipment manufacturing, precision digital healthcare, and operational maintenance services [1] - The company focuses on merging advanced medical technology with finance and services to provide a full-process solution for ion therapy, including equipment layout, financial support, operation and maintenance, consulting services, personnel training, and big data services [1] Group 2: Product Development - The company has invested significantly in R&D for new products, recently developing the world's first light ion combined treatment device, which can provide proton and helium ion beams at 230 MeV/u for clinical treatment, as well as carbon ion beams for tumor treatment in specific body areas [1] - The new device occupies only 1500 m² and significantly reduces equipment and construction costs compared to traditional heavy ion therapy devices, addressing the high comprehensive investment issue associated with ion therapy [1] Group 3: Strategic Investment and Goals - The introduction of strategic investors will help Guoke Ion strengthen its core technological advantages, accelerate international market expansion, and stabilize its strategic planning while improving corporate governance [2] - The company plans to leverage its AI center to connect ion therapy devices nationwide, gather quality medical resources, and reconstruct the diagnosis and treatment process using intelligent technology to achieve strategic goals [2]